News & Events

  • February 03, 2012

    Generex Biotechnology Corporation announced the closing of their PIPE offering in the amount of $2,000,000. EG&S acted as counsel to Generex.
     

  • February 02, 2012

    Hyperdynamics Corporation announced the closing of their Registered Direct offering in the amount of $30,000,000. EG&S acted as counsel to the placement agent.
     

  • January 30, 2012

    Cel-Sci Corporation announced the closing of their Registered Direct offering in the amount of $5,760,000.  EG&S acted as counsel to the placement agent.
     

  • January 20, 2012

    DARA BioSciences, Inc. announced the closing of their Registered Direct offering in the amount of $1,700,000. EG&S acted as counsel to the placement agent.
     

  • January 18, 2012

    NutraCea announced the closing of their PIPE offering in the amount of $870,000. EG&S acted as counsel to NutraCea.
     

  • January 17, 2012

    Barry Grossman gave a presentation on the requirements and methodologies used to Go Private and participated on a panel discussing Privatization of Chinese Companies.

    Click here to view the presentation

  • January 11, 2012

    Ellenoff Grossman & Schole LLP was ranked #4 for issuer representation in IPO transactions  (by number of transactions) for 2011.

    Click here to view the rankings

  • January 04, 2012

    Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for 2011.

    Click here to view the rankings

  • December 30, 2011

    AspenBio Pharma, Inc. announced the closing of their registered direct offering in the amount of $1,637,100.  EG&S acted as counsel to the Placement Agent.
     

  • December 28, 2011

    Oculus Innovative Sciences, Inc. announced the closing of their registered direct offering in the amount of $2,081,100.  EG&S acted as counsel to the Placement Agent.
     

  • December 28, 2011

    Quadrant 4 Systems Corporation announced the closing of their private placement in the amount of $800,000.  EG&S acted as counsel to the Investor.
     

  • December 27, 2011

    Catasys, Inc. announced the closing of their registered direct offering in the amount of $974,999. EG&S acted as counsel to the Placement Agent.
     

  • December 21, 2011

    StemCells, Inc. announced the closing of their underwritten public offering in the amount of $10,000,000. EG&S acted as counsel to the Underwriter.
     

  • December 13, 2011

    PhotoMedex, Inc., a NASDAQ listed company, and Radiancy, Inc., a private Delaware company,  announced the completion of their merger.  Pursuant to the merger, the former stockholders of Radiancy received shares of Photomedex valued on the date of closing at approximately $235 million and collectively own approximately 75% of PhotoMedex, Inc. following the merger. Radiancy became a majority-owned subsidiary of PhotoMedex. EG&S acted as counsel to Radiancy.

  • December 13, 2011

    Cell Therapeutics Inc. announced the closing of their registered direct in the amount of $20,000,000. EG&S acted as counsel to the Placement Agent.

  • December 07, 2011

    Capitol C Holdings LLC announced the completion of its refinancing of senior secured debt with NCB, FSB.  EG&S acted as counsel to Capitol C Holdings.

  • December 06, 2011

    Celsion Corporation announced the closing of their PIPE offering in the amount of $15,000,00.  EG&S acted as counsel to the Placement Agent.
     

  • November 23, 2011

    IceWEB, Inc. announced the closing of their private placement in the amount of $1,750,000.00. EG&S acted as counsel to the Placement Agent.
     

  • November 16, 2011

    Adventrx Pharmaceuticals, Inc. (AMEX: ANX) announced the completion of its underwritten public offering of common stock and warrants in the amount of $17,000,000.  EG&S acted as counsel to the underwriter.

  • November 16, 2011

    Bluff Point Associates Corp. announced the acquisition of a controlling interest in Connexin Software, Inc. of Connexin Software, Inc. for the amount of $6,375,000. EG&S acted as counsel to Bluff Point Associates Corp.

  • November 14, 2011

    InvestLink Technologies, LLC announced the sale of Interests to Aspire Financial Services, LLC. EG&S acted as counsel to the principals of InvestLink Technologies, LLC.
     

  • November 08, 2011

    Bluff Point Associates acquired majority ownership of fi360 Inc., a leading provider of educational training programs, professional designations and analytical and reporting technology for fiduciaries and financial service providers. EG&S acted as counsel to Bluff Point Associates.

  • November 08, 2011

    Thing Daemon, Inc., which owns and operates social media websites including theFancy.com, raised $10 million in private equity funding from a group of investors led by an affiliate of PPR, S.A. PPR is a global conglomerate of luxury brands including Gucci, Bottega Veneta and Yves Saint Laurent. EG&S acted as counsel to Thing Daemon.

  • November 08, 2011

    Pressure Biosciences, Inc. announced the closing of their registered direct in the amount of $842,999.95. EG&S acted as counsel to the Placement Agent.

  • November 08, 2011

    Ellenoff Grossman & Schole LLP represented affiliates of The Pyramid Companies in connection with the refinance of mortgage loans encumbering two of Pyramid’s larger retail centers: Palisades Center in West Nyack, New York, and Poughkeepsie Galleria Mall in Poughkeepsie, New York.

    The $525 Million Dollar and $176 Million Dollar mortgage and mezzanine loans on the Palisades Center and Poughkeepsie Galleria Mall, respectively, were separate transactions with major institutional lenders, and closed concurrently on the same day. 

    Click here to view complete details of the transaction